SASaro Abdella Abrahim

Saro Abdella Abrahim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saro Abdella Abrahim has a total of 223 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Genomic analysis of early case samples from the 2025 Marburg virus outbreak in Ethiopia

    by Mekdes Daba Feyssa, Getachew Tollera, Saro Abdella, Chala Bashea, Betselot Zerihun, Melkamu Abte, Melak Getu, Adimkewu Agunie, Wolde Shure, Gebremedhin Gebremicael, et al.


  • Open Access

    Blood safety in Ethiopia: policy, practice and regulation

    by Elizabeth Speakman, Saro Abdella, John Dillon, Sarah K Inglis, Habtamu Taye, Christie Cabral

    Aim: To examine blood safety policy, practice and regulation in Ethiopia, identifying ongoing challenges and facilitators. Background: As Ethiopia transitions to lower-middle-income status, it faces increased demands on its health system. Accessible safe blood for transfusion is a key requirement and Ethiopia aims to achieve international accreditation of blood safety. Methods: Literature and policy review of blood safety and regulation in Africa, focused on Ethiopia. Data collection included searching of six databases, purposive hand-searching of reference lists and websites and stakeholder consultation. Data were screened and a narrative synthesis was conducted. Findings: Ethiopia has made significant progress in increasing numbers of blood banks and voluntary blood donors. Endemic transfusion transmissible infections, adequate funding and effective haemovigilance remain challenging, and an enforceable regulatory framework is not yet in place. This is due to resource constraints (particularly of trained staff) compounded by challenging contextual issues. Conclusions: Reaching international standards of blood safety is only achievable with adequate resourcing and planning, including increased government funding and international support. Funding: This article presents independent research funded by the National Institute for Health and Care Research (NIHR) Global Health Research programme as award number NIHR133208.

  • Open Access

    A scoping review on HCV screening strategies: population to screen and the test types

    by Saro Abdella Abrahim, Andrew Radley, Sarah K. Inglis, Zelalem Kebede, Abeje Kebede, Getahun Fetensa, Andargachew Mulu, Wondwossen Amogne, Dawit Wolday, John Dillon

    Hepatitis C virus (HCV) is a genetically diverse blood-borne pathogen causing liver inflammation and damage. It is one of the global public health problems responsible for claiming thousands of lives every year. Although there are various HCV testing strategies depending on the specific circumstances and guidance of local authorities, the proportion of diagnosed HCV cases in Low- and Middle-Income Countries (LMICs) is estimated to be less than 5%. This review analyzes and documents evidence for different ways of screening HCV. The updated Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines have been used as the basis for this scoping review. Retrieved articles were screened and extracted by three independent individuals to make sure that all pertinent literatures were included. A total of 8318 records were retrieved from four electronic databases (Scopus, PubMed, CINAHL and Google Scholar). Of the total retrieved records and after applying the pre-defined inclusion criteria, we included 51 studies in this review. According to the studies included in this review, three major screening approaches were noted: The universal, targeted, and risk-based HCV screening strategies. Population to screen include the baby boomer cohort, pregnant women, key populations, those experiencing homelessness, adults visiting health facilities, employees, and social event attendants. A “one-stop-shop” HCV testing initiative at different settings, such as prisons, addiction rehabilitation centers, and community dropping centers, were found to increase HCV test uptake among key populations. Integrating HCV screening with the existing HIV and Sexually Transmitted Infection (STI) clinics was highlighted to identifying and linking HCV-infected individuals to appropriate care and treatment. Although there are many ways of diagnosing HCV for treatment, identifying those who were reactive for HCV antibody first, followed by an HCV-antigen test for those antibody-positive, were found to be the most cost-efficient way of diagnosing HCV infection. HCV screening among pregnant women, the baby boomer cohort, adults visiting health facilities, engaging in injection drug use, incarcerated individuals, and those experiencing homelessness are useful approaches in identifying HCV-antibody positive individuals. An efficient way to reach the most at-risk people is to incorporate HCV screening into community service centers and clinics.


  • Open Access

    The Ethiopian Third National Tuberculosis Drug Resistance Survey Incorporating Whole Genome Sequencing

    by Shewki Moga, Muluwork Getahun, Zemedu Mohammed, Ayinalem Alemu, Getu Diriba, Bazezew Yenew, Dinka Fikadu, Yeshiwork Abebaw, Misikir Amare, Ephrem Tesfaye, et al.

    Background: Drug-resistant tuberculosis (DR-TB) is a major challenge hindering global tuberculosis control. Ethiopia conducted a third national antituberculosis (TB) drug resistance survey, and this is the first survey to report on drug resistance using whole genome sequencing (WGS) in addition to genotypic and phenotypic test results. The aim of this study was to obtain up-to-date information regarding the magnitude and pattern of drug resistance in Ethiopia. Methods: A nationwide cross-sectional study was conducted in 217 health facilities across all Ethiopian regional states from August 2017 to January 2019. Sputum specimens were collected from patients with bacteriologically confirmed pulmonary TB to detect resistance to anti-TB drugs with Xpert MTB/RIF assay, culture-based phenotypic drug susceptibility testing (DST), and WGS with phylogenetic analysis. Results: The prevalence of rifampicin-resistant TB (RR-TB) was 1.07% (95% confidence interval [CI], .65%–1.74%) among new cases and 6.89% (95% CI, 4.02%–11.57%) among previously treated cases. The prevalence of isoniazid-resistant, rifampicin-susceptible TB was 4.15% (95% CI, 3.11%–5.53%) among new cases and 4.41% (95% CI, 1.97%–9.57%) among previously treated cases. While resistance to fluoroquinolones was detected in 1 RR-TB case, resistance to bedaquiline and linezolid was not detected in RR-TB cases. Mycobacterium tuberculosis lineage 4 was the most common, followed by lineage 3 and lineage 1, with sublineage 4.2.2 being the most frequent. Conclusions: The level of RR-TB remained low. Expanding baseline DST for isoniazid may help further lower the burden of DR-TB in Ethiopia.


  • Open Access

    Lineage B Genotype III of Dengue Virus Serotype 3 (DENV-3III_B) Is Responsible for Dengue Outbreak in Dire Dawa City, Ethiopia, 2023

    by Abebe Aseffa Negeri, Dawit Hailu Alemayehu, Saro Abdella Abrahim, Tsigereda Kifle Wolde, Gutema Bulti Tura, Alemnesh Hailemariam Bedasso, Danile Tsega Geretsion, Ebise Abose Djirata, Eyilachew Zenebe Awule, Diana Rojas-Gallardo, et al.

    The eastern parts of Ethiopia, including Dire Dawa City, have experienced annual dengue fever (DF) outbreaks since 2013, leading to significant healthcare and economic impacts. However, comprehensive evidence on the specific dengue virus (DENV) serotypes and genotypes involved remains limited. During the 2023 DF outbreak, the National Arbovirus Laboratory received seventy serum samples from suspected DF patients. Positive samples underwent sequencing of the CprM region of the DENV genome, and the obtained sequences were analyzed phylogenetically. Among the patients, 32 (45.7%) displayed early warning signs of severe dengue, and 13 were hospitalized, most showing symptoms indicative of severe dengue. Out of 67 adequate samples, 44 (65.6%) tested positive for DENV RNA by RT-PCR, and 17 successfully underwent CprM sequencing. All sequenced samples were identified as DENV-3, genotype III, major lineage B (DENV-3III_B), with two distinct minor lineages (DENV-3III_B.2 and DENV-3III_B.3). Phylogenetic analysis showed that these lineages were closely related to sequences from the Afar region, suggesting interconnected outbreaks with multiple co-circulating lineages. This study identifies DENV-3III_B as the cause of the 2023 DF outbreak in Dire Dawa City and highlights the need for enhanced viral genomic surveillance in Africa.


  • Open Access

    Vaccine uptake, barriers and enhancers of COVID-19 vaccination among healthcare workers from high-burden cities in Ethiopia

    by Gutema B. Tura, Derbachew A. Teni, Saro Abdella, Jaleta B. Tura, Yakob Wondarad, Getahun Fetensa, Tesfaye Gelanew, Alemseged Abdissa, Senga Sembuche, Elizabeth Gonese, et al.

    Background: Coronavirus disease 2019 (COVID-19) vaccination is crucial for healthcare workers (HCWs) to protect themselves and promote public health. Aim: This study assessed COVID-19 vaccination uptake, barriers and enhancers among HCWs in high-burden cities in Ethiopia. Setting: A cross-sectional survey among 600 randomly selected HCWs from 30 health facilities (May 2023 to July 2023). Methods: Interviewer-administered questionnaires assessed vaccination status, concerns and motivators. Descriptive statistics and modified Poisson regression identified factors associated with vaccination. Results: Overall, 70.3% (n = 422) received at least one dose, and 39.2% (n = 235) were fully vaccinated. Safety concerns (51.9%) were the main barrier. More information on safety and efficacy (53.1%) and regulatory approval (27.3%) were key motivators. Those not recommending vaccination were less likely to be vaccinated (prevalence ratio [PR] = 0.59, 95% confidence interval [CI]: 0.41–0.85). Professionals such as radiographers (PR = 0.78), pharmacists (PR = 0.79) and laboratory personnel (PR = 0.85) were less likely compared to physicians. Older HCWs (> 25 years) were twice as likely to be vaccinated. HCWs in health centres were more likely to be vaccinated than those in hospitals (PR = 1.201, 95% CI: 1.076–1.341). Conclusion: A significant proportion of HCWs were not fully vaccinated. Targeting hospital workers and younger age groups and improving HCWs confidence in recommending vaccination can increase uptake. Contribution: This study reveals COVID-19 vaccine safety, efficacy and confidence concerns of HCWs, highlighting the need for targeted awareness to strengthen national vaccination efforts against pandemics.


  • Open Access

    HIV Viral Non-Suppression and Its Associated Factors Among PMTCT Mothers Receiving ARV Treatment in Ethiopia

    by Belete Woldesemayat, Ajanaw Yizengaw, Aschale Worku, Amelework Yilma, Sisay Adane, Jaleta Bulti, Eleni Kidane, Gutema Bulti, Saro Abdella

    Background: Pediatric HIV infection is mainly caused by Mother-to-child transmission (MTCT). Without any effective medical intervention, 15-45% of infants born to HIV-positive women will become infected with HIV. The contribution of viral non-suppression for MTCT is high. Hence, this study was to determine the magnitude of HIV viral non-suppression, and associated factors among PMTCT Mothers in Ethiopia. Methods: The study was conducted from April 1, 2023, to December 31/ 2024 at 16 public health facilities. An institutional-based cross-sectional study was employed and 496 HIV-positive pregnant and lactating women on ART were included. Data was collected using a prechecked questionnaire with paper mode and ODK (Open Data Kit) for each participant. Venous blood was collected using two Ethylenediamine Tetra acetic Acid (EDTA) tubes for HIV viral load, CD4 and Hgb test. HIV viral load tests were conducted at the EPHI (Ethiopian Public Health Institute) National HIV reference laboratory using the COBAS 4800 System (Roche Molecular Diagnostics). Data was edited and exported to SPSS from the ODK data file, and finally data analysis was performed using SPSS version 26 software. Results: 496 PMTCT Mothers were included in this study, the prevalence of HIV viral non-suppression was 2.2% (95% CI; 1.1-3.9), the rate of viral detectability was 21.8 % (95% CI; 18.2-25.7) and the rate of low-level viremia (LLV) was 9.1%. Family size (X 2 =7.20; p2 =18.553; p2 =25.29; p2 =25.29; p2 =4.408; p=0.036), and low survey time CD4 count (2 = 15.989; p<0.001) were significantly associated to the rate of HIV viral non-suppression. Conclusions: In this study, HIV viral non-suppression among pregnant and lactating women is relatively low (meet the UNAIDS 2030 target). However, Family size, level of Adherence, exposure to opportunistic infection, WHO clinical stage level II and III, HIV status disclosure and low CD4 count were significantly associated with the prevalence of viral non-suppression. To achieve persistent HIV viral suppression enhanced adherence and counselling services should be provided, tailored to the needs of the specific target group.

  • Open Access

    HIV treatment cascade among female sex workers in Ethiopia: Assessment against the UNAIDS 90-90-90 targets

    by Saro Abdella, Meaza Demissie, Alemayehu Worku, Merga Dheresa, Yemane Berhane

    Background: HIV treatment cascades for HIV-positive female sex workers (FSWs) have been challenged by the overlapping stigma and discrimination associated with both their sex work and HIV status. This study aims to assess the proportion of HIV-positive FSWs who access care and treatment in Ethiopia. Method: A cross-sectional study with a respondent-driven sampling technique was used to enroll 6,085 female sex workers from January to June 2020. Interviews were conducted to assess the FSWs’ HIV status awareness and access to ART. A blood sample was drawn to determine the current HIV status and viral load level. Logistic regression was run to identify factors associated with FSWs’ HIV status awareness. Results: Of the total 1140 HIV-positive FSWs, 50.38% knew they were HIV positive; 92.88% of those who knew their status were on ART, and 91.68% of those on ART had attained viral suppression of less than 1000 copies per milliliter. The adjusted odds of knowing HIV status was 3.20 (95% CI; 2.00, 5.13) among those aged 35 years and older, 1.81 (95% CI; 1.05, 3.12) among widowed, and 1.73 (95% CI; 1.28, 2.32) in those who did not perceive the risk of HIV acquisition. Conclusion: Only about half of HIV-positive FSWs knew they were HIV positive. More than 90% of those who knew their status were put on ART and achieved viral suppression. The weakest point in achieving HIV control among FSWs is the identification of those living with HIV.


  • Open Access

    The effect of drop-in centers on access to HIV testing, case finding, and condom use among female sex workers in Addis Ababa, Ethiopia

    by Saro Abdella Abrahim, Meaza Demissie, Alemayehu Worku, Merga Dheresa, Yemane Berhane

    Background Varied HIV prevention interventions involving multiple strategies has been instrumental in the effort to contain and lessen the prevalence of HIV around the globe. However, female sex workers (FSWs) often face stigma and discriminatory challenges, resulting in lower access to the HIV prevention initiatives. This study has aimed to assess the effect of one of the HIV service delivery models, the Drop-in Centers (DICs), which is designed to overcome the service uptake barriers of FSWs. Method A quasi-experimental study design was employed. A respondent-driven sampling technique was used to recruit 1,366 FSWs from January to June 2020. A propensity score matching technique was used to balance the potential confounders between FSWs who had access to DICs and those who had never accessed DICs. Comparisons of the effect of DIC on the outcome of interest was made using a logit regression model at a 5% level of significance. Results A total of 1,366 FSWs took part in the study. The analysis estimated the average treatment effects of access to DICs on four key outcomes: ever-testing to know HIV status, finding HIV-positive FSWs, awareness of HIV-positive status, and consistent condom use. A significant effect of DIC was seen at a 95% confidence interval on each outcome. Access to DIC produced a 7.58% increase in the probability of testing to know HIV status (P < 0.001), a 7.02% increment in finding HIV-positive FSWs (P = 0.003), an increase of 6.93% in awareness of HIV status among HIV positive FSWs (P = 0.001), and a 4.39% rise in consistent condom use (P = 0.01). Conclusions Ensuring access of FSWs to DICs has led to an upsurge in HIV testing among FSWs, raising HIV status awareness among those who are HIV positive, and encouraged consistent condom use. To provide effective HIV prevention services, particularly to those FSWs living with HIV, it is essential to strengthen the services provided in DICs and expand the centers. This will ensure that the entire network of FSWs is reached with appropriate HIV prevention services.


  • Open Access

    Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants

    by Gadissa Gutema, Habteyes Hailu Tola, Dinka Fikadu, Dereje Leta, Birra Bejiga, Jaleta Bulti Tura, Saro Abdella, Hassen Mamo

    Background: Mother-To-Child-Transmission (MTCT) of Human Immunodeficiency Virus (HIV) occurs during pregnancy, delivery and breastfeeding, and cause infection among several new-borns. However, there is limited recent evidence on the burden of MTCT of HIV in Ethiopia from a large-scale data. Thus, this study aimed to determine the positivity rate, trend and associated risk factors of MTCT among HIV-exposed infants. Methodology: A cross-sectional study was conducted among 5,679 infants whose specimen referred to Ethiopian Public Health Institute HIV referral laboratory for Early Infant Diagnosis (EID) from January 01, 2016, to December 31, 2020. Data were extracted from the national EID database. Frequencies and percentages were used to summarize the data on characteristics of infants. Logistic regression analysis was employed to identify factors associated with positivity rate of MTCT of HIV. Level of significance was set at 5%. Results: The mean age of the infants was 12.6 (± 14.6) weeks with an age range of 4 to 72 weeks. Half of the infants (51.4%) were female. The positivity rate of MTCT decreased from 2.9% in 2016 to 0.9% in 2020 with five-year average positivity rate of 2.6%. HIV test after six weeks (Adjusted odds ratio (AOR) = 2.7; 95% confidence interval (CI): (1.8–4.0,)); p < 0.001), absence of prevention of mother-to-child-transmission (PMTCT) service (AOR = 4.6; 95% CI: (2.9–7.4)); p = 0.001), nevirapine prophylaxis not received (AOR = 2.0; 95% CI: (1.3–3.2)); p < 0.001), and unknown ART status of the mother at delivery (AOR = 11; 95% CI: (5.5–22.1)); p < 0.001) were significantly associated with MTCT of HIV. Conclusion: The positivity rate of MTCT of HIV was showing declining tendency gradually in the study period. Strengthening PMTCT service, early HIV screening and starting ART for pregnant women, and early infant diagnosis are required to reduce the burden of HIV infection among infants exposed to HIV.